Joo, LiJin
Bradley, Catherine C.
Lin, Steven H.
Scheet, Paul A.
Nead, Kevin T. http://orcid.org/0000-0001-9680-8298
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RR190077)
National Cancer Institute (CA016672, K08CA263313, L30CA253796)
Article History
Accepted: 1 November 2022
First Online: 31 January 2023
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: LiJin Joo, Catherine C. Bradley, Paul A. Scheet, and Kevin T. Nead declare no conflict of interest. Steven H. Lin has received grants or contracts from STCube Pharmaceuticals, Beyond Spring Pharmaceuticals, and Nektar Therapeutics; consulting fees from XRAD Therapeutics; and has participated on a Data Safety Monitoring or Advisory Boards for Creatv Microtech and AstraZeneca.